Evidence map›Paper›PMID 40856292›Full record

ReviewPsychological medicine2025

Unlocking mental health insights with UK Biobank data: Past use and future opportunities.

Katrina A S Davis, Luwaiza Mirza, Scott R Clark, Jonathan R I Coleman, Aliyah S Kassam, Natalie T Mills, Amy Zadow, Andrew M McIntosh, Matthew Hotopf

Abstract readReview
In one paragraph

Review in Psychological medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Katrina A S DavisKing's College London Institute of Psychiatry, Psychology and Neuroscience, London, England, UK.ORCID 0000-0001-5945-4646
Luwaiza MirzaWest London NHS Trust, Mental Health Services, London, England, UK.
Scott R ClarkUniversity of Adelaide, Discipline of Psychiatry, South Australia, Australia.
Jonathan R I ColemanKing's College London Institute of Psychiatry, Psychology and Neuroscience, London, England, UK.ORCID 0000-0002-6759-0944
Aliyah S KassamSouth London and Maudsley NHS Trust, Biomedical Research Centre, London, England, UK.ORCID 0009-0002-9317-8344
Natalie T MillsUniversity of Adelaide, Discipline of Psychiatry, South Australia, Australia.
Amy ZadowUniversity of Adelaide, Faculty of Health and Medical Sciences, South Australia, Australia.
Andrew M McIntoshUniversity of Edinburgh, Division of Psychiatry, Edinburgh, Scotland, UK.ORCID 0000-0002-0198-4588
Matthew HotopfKing's College London Institute of Psychiatry, Psychology and Neuroscience, London, England, UK.ORCID 0000-0002-3980-4466

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

UK Biobank (UKB) is a large-scale, prospective resource offering significant opportunities for mental health research. Data include genetic and biological data, healthcare linkage, and mental health enhancements. Challenges arise from incomplete linkage of some sources and the incomplete coverage for enhancements, which also occur at different times post-baseline. We searched for publications using UKB for mental health research from 2016 to 2023 to describe and inspire future use. Papers were classified by mental health topic, 'additional' aspects, and the data used to define the mental health topic. We identified 480 papers, with 338 focusing on mental health disorder topics (affective, anxiety, psychotic, multiple, and transdiagnostic). The most commonly studied disorder was depression (41%). The most common single method of ascertaining mental disorder status was the Mental Health Questionnaire (26%), with genetic risk, for example, using polygenic risk scores, also frequent (21%). Common additional aspects included brain imaging, gene-environment interaction, and the relationship with physical health. The review demonstrates the value of UKB to mental health research. We explore the strengths and weaknesses, producing resources informed by the review. A strength is the flexibility: conventional epidemiological studies are present, but also genomics, imaging, and other tools for understanding mental health. A major weakness is selection effects. UKB continues to hold potential, especially with additional data continuing to become available.

Indexed as

Biological Specimen BanksBiomedical ResearchMental DisordersMental HealthHumansUK BiobankUnited Kingdomcohort studyepidemiologymental healthmethodologyresearchUK Biobank

Identifiers

PMID40856292
PMCPMC12404320

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.